Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
4.050
0.00 (0.00%)
At close: Oct 17, 2025, 4:00 PM EDT
4.140
+0.090 (2.22%)
After-hours: Oct 17, 2025, 7:51 PM EDT
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $124.26 million as of October 17, 2025. Its market cap has increased by 53.02% in one year.
Market Cap
124.26M
Enterprise Value
63.43M
1-Year Change
53.02%
Ranking
Category
Stock Price
$4.05
Market Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $124.26M, an increase of 1,236.09%. That is a compound annual growth rate of 31.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 124.30M | 51.40% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
| May 11, 2016 | 9.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |